AOL Money & Finance

Options Update: Dendreon options indicate movement into data

Posted Apr 14th 2009 8:00AM by Paul FosterPaul Foster RSS Feed
Filed under: Options

More

Dendreon (NYSE: DNDN) was halted at $7.30. DNDN is reporting top-line data from the ongoing Phase 3 IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment) this morning. DNDN April 7 straddle is priced at $1.87, May 7 straddle is priced at $6.60 according to Track Data, suggesting large price movement.

NASDAQ 100 (NASDAQ:QQQQ) overall implied volatility at 36; 26-week average is 43. CBOE Volatility Index S&P 500 Options-VIX at 37.81; 10-day moving average is 40.82.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Tags: CBOE Volatility Index SP 500 Options-VIX, CboeVolatilityIndexSp500Options-vix, Dendreon, Immunotherapy for Prostate AdenoCarcinoma Treatment, ImmunotherapyForProstateAdenocarcinomaTreatment, NASDAQ 100 QQQQ, Nasdaq100Qqqq, option implied volatility, OptionImpliedVolatility

Symbol Lookup
IndexesChangePrice
DJIA+132.7910,450.95
NASDAQ+29.972,176.01
S&P 500+14.861,106.24

Last updated: November 23, 2009: 04:22 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines